PPARA and Hepatic fibrosis: Previous manuscripts have reported that PPAR-α agonists Wy-14643 and fenofibrate may prevent the development of hepatic fibrosis in the rat thioacetamide (TAA) and methionine choline-deficient (MCD) models of liver fibrosis [11, 12].